Medtronic delivers real | 合法醫療器材資訊網

2020年6月29日—Medtronicdeliversreal-worldrenaldenervationdatashowingbetterbloodpressureafter3years...Medtronic'syears-longefforttodevelop ...

Medtronics years-long effort to develop renal denervation into a therapy continues, with promising new data from a three-year registry. More than 2,500 international patients with uncontrolled high blood pressure showed real-world improvements in their numbers following treatment with the medtech giants Symplicity system, regardless of any heart medications they were taking.

The procedure demonstrated significant drops in office-measured systolic blood pressure, by 17 mmHg, leading to more patients achieving a blood pressure of below 140. Meanwhile, those with very high levels of hypertension saw their readings fall into ranges associated with fewer health risks.

Additionally, the total number of patients in the registry with the highest blood pressures—more than 180 mmHg at the start—decreased by two-thirds over the three-year period. All this occurred while the participating patients...